Bevacizumab does not increase risk of perforation in patients undergoing percutaneous endoscopic gastrostomy or jejunostomy placement Meeting Abstract

  

Authors:	Dibba, P.; Schattner, M. A.; Mendelsohn, R.
Abstract Title:	Bevacizumab does not increase risk of perforation in patients undergoing percutaneous endoscopic gastrostomy or jejunostomy placement
Meeting Title:	2019 American Society for Gastrointestinal Endoscopy (ASGE) Digestive Disease Week (DDW)
Keywords:	gastrointestinal perforation
Journal Title:	Gastrointestinal Endoscopy
Volume:	89
Issue:	6 Suppl.
Meeting Dates:	2019 May 18-21
Meeting Location:	San Diego, CA
ISSN:	0016-5107
Publisher:	Mosby Elsevier
Date Published:	2019-06-01
Start Page:	AB486
Language:	English
ACCESSION:	WOS:000470094902196
DOI:	10.1016/j.gie.2019.03.793
PROVIDER:	wos
Notes:	Meeting Abstract: Mo1314 -- Source: Wos